Diane PhD

Scientific Consultant: Director of Huntington's Disease Preclinical Development at NeuBase Therapeutics - Pittsburgh, PA, US

Diane PhD's Contact Details
HQ
N/A
Location
Pittsburgh, PA
Company
NeuBase Therapeutics
Diane PhD's Company Details
NeuBase Therapeutics logo, NeuBase Therapeutics contact details

NeuBase Therapeutics

Pittsburgh, PA, US • 50 - 99 Employees
Major Drugs

NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase's pipeline includes therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington's disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been "undruggable."

Biotechnology Gene Silencing Antisense Oligonucleotide Therapies Rare Disease Genetic Disease Huntington's Disease Myotonic Dystrophy CNS Disease Huntington's Disease
Details about NeuBase Therapeutics
Frequently Asked Questions about Diane PhD
Diane PhD currently works for NeuBase Therapeutics.
Diane PhD's role at NeuBase Therapeutics is Scientific Consultant: Director of Huntington's Disease Preclinical Development.
Diane PhD's email address is ***@neubasetherapeutics.com. To view Diane PhD's full email address, please signup to ConnectPlex.
Diane PhD works in the Major Drugs industry.
Diane PhD's colleagues at NeuBase Therapeutics are William Riedl, Eunah Cho, Bridget Sawyer-Revels, Thomas Zengeya, Valentina Caro, Mykaela Wagner, Matthew Koch and others.
Diane PhD's phone number is N/A
See more information about Diane PhD